Fortification with BC was also associated with a blood immune profile that reflected higher levels of anti-inflammatory/TH2/TReg cytokines (e.g. IL-10) and lower levels of pro-inflammatory/TH1/TH17-related cytokines (e.g. IL-15, IL-17, GM-CSF), most clearly after 1 week of fortification. The gene discussed is IL15; the disease is breast cancer.